Cognitive Screening in Primary Care. Marilyn Malone, MHSc, MD, FRCPC Geriatric Medicine March 18, 2015
|
|
- Victor Cameron
- 7 years ago
- Views:
Transcription
1 Cognitive Screening in Primary Care Marilyn Malone, MHSc, MD, FRCPC Geriatric Medicine March 18, 2015
2 Objectives Know how to define and differentiate mild cognitive impairment from dementia syndromes. Better understand the use of and interpretation of common cognitive screening tools
3 Cognitive Screening in Primary Care What is dementia? What is mild cognitive impairment (MCI)? Who is at risk? Tool kit Mini-Cog Clock drawing MoCA MMSE Case examples
4 What is Dementia? Demonstrable impairment of memory (DSM-4) Other impairment in at least one of: Language (naming) Judgment / executive function Construction / visuospatial function Abstraction Personality Impairment interferes with function and ADL Insidious, and > 6 months (ICD-10)
5 What is Dementia? DSM 5: neurocognitive disorder Mild Moderate Severe
6 Dementia IS NOT a test score
7 Collateral history is crucial
8 Prevalence of Dementia in Canada 8% of 65+ yr olds Almost 50% of 85+ yr olds
9 Who is at risk? Age Risk doubles every 5 yrs Family Hx Risk doubles for each 1 st degree relative Cardiovascular disease Risk doubles for each vascular risk factor AGE % < Risk 15% justifies cognitive assessment.
10 Case #1: Mr. A. Phib You have known Mr. A. Phib, age 65, for about 3 years. He missed his last 2 routine appointments, and you have concerns since it has been more difficult to titrate his INR. You wonder if he stopped taking his warfarin as prescribed. He has never complained about memory, and has no family. You wonder if he should have his memory checked. He comes in for a 15 minute appointment. What next?
11 Mr. Phib, age 65, 1 vascular risk factor AGE % < Dementia risk is 2 x 2 = 4% Due to low calculated risk, a full cognitive assessment isn t usually indicated. Therefore, you decide to do a Mini-Cog rather than an MMSE.
12 Mr. Phib, Mini-Cog Scenario 1: Step 1: Register 3 words Step 2: Draw a clock Step 3: Word recall Remembers 1 of 3 words Step 4: Score Normal clock, 1/3 words = negative screen for dementia
13 Mr. Phib, Mini-Cog Scenario 2: Step 1: Register 3 words Step 2: Draw a clock Step 3: Word recall Remembers 2 of 3 words Step 4: Score Abnormal clock, 2/3 words = positive screen for dementia
14 Collateral history is crucial
15 Case #2: Ms. Diane Bettick Ms. Diane Bettick, age 60, is well known to you, and has been your patient for 20 years. She used to be a hospital administrator and has been enjoying the good life since retiring 4 years ago. She is an avid golfer and sometimes you see her forcing her clubs into the tiny trunk of her convertible after finishing a round. She has Type 2 DM with HbA1C of 6.8%, controlled HTN with BP 124/80, stable ischemic heart disease, lipids well controlled on atorvastatin. You have never worried about her cognition, but her husband says she is having difficulty managing money. Also, he thought she seemed confused and overwhelmed at the Heathrow airport when they went to visit relatives over Christmas. She comes in for a 15 minute appointment without her husband. What next?
16 Ms. Bettick, age 60, 4 vascular risk factors AGE % < Dementia risk is 1 x 2 x 2 x 2 x 2 = 16% Due to high calculated risk, you decide to do a full screening test. What test do you do?
17 Ms. Bettick, Mini-Cog: Step 1: Register 3 words Step 2: Draw a clock Step 3: Word recall Remembers 2 of 3 words Step 4: Score Abnormal clock, 2/3 words = positive screen for dementia
18
19 Ms. Bettick MoCA score 18/30 Now what? Does she have a dementia or not?
20 Ms. Bettick, Clock + MMSE Temporal Orientation: Spring, Saturday, April 8, 2010 Spatial Orientation: all correct Registration: one trial Attention/Calculation: D L O R W Recall: 2 out of 3 Naming: all correct Repetition: all correct 3-stage command: all correct CLOSE YOUR EYES correct Written sentence: This is stupid Pentagon copy: all correct MMSE score 27/30 Now what?
21 Ms. Bettick, next steps She failed the Mini-Cog, MMSE 27/30, MoCA 18/30 Collateral information from husband suggests there is functional impairment (finances, travelling) You correctly conclude that she has an early dementia What about driving? What about more investigations? What about treatment?
22
23 Case #3: Miss Ida Frett Miss Ida Frett is a new patient to you. She is a retired school librarian, lives alone, and takes the bus to church on Sundays. She takes various vitamins and herbal remedies but no other medications. She is terribly worried that she has early Alzheimer s disease and wants to get checked out. Both parents had Alzheimer s in their late 80 s, and she just turned 84. What next?
24 Miss Frett, age 84, no vascular risk factors, both parents had AD AGE % < Dementia risk is 16 x 2 x 2 = 64% Due to high calculated risk, you decide to do a full screening test. What test do you do?
25 Miss Frett, Clock + MMSE Temporal Orientation: Spring, Saturday, April 10, 2010 Spatial Orientation: all correct Registration: one trial Attention/Calculation: D L R O W Recall: 3 out of 3 Naming: all correct Repetition: all correct 3-stage command: all correct Written sentence: You are the best doctor in the world Pentagon copy: all correct MMSE score 30/30 Now what?
26 Miss Frett MoCA score 25/30 Now what? Does she have a dementia or not?
27
28 Miss Frett You correctly determine that she has MCI Her specific risk for dementia is: 12% per year 50% at 5 years At 5 years, she has a 30% chance of being the same, and a 20% chance of improvement without intervention You ask your nurse to recheck the MoCA in 6 months.
29 Case #4: Mrs. Ima Strong Mrs. Strong is an 86 year old lady with known dementia and frequent falls. Her 90 year old husband brought her in for an annual checkup you hear Ima yelling at him in the waiting room. Last year she scored 23/30 on an MMSE, and you recommended home supports that she promptly fired. She doesn t take any medications except Ativan for sleep. Both Ima and her husband Ernest look exhausted. Ima looks thin and disheveled, and Ernie is trying not to cry. What next?
30 Mrs. Strong, Clock + MMSE Temporal Orientation: Fall, September, 1929 Spatial Orientation: Victoria, Canada Registration: one trial Attention/Calculation: D L O D Recall: 0 out of 3 Naming: 1 correct Repetition: No ifs or buss 3-stage command: 2 correct steps CLOSE YOUR EYES correct with a prompt Written sentence: I love you Pentagon copy: no overlap MMSE score 12/30 Now what?
31 Mrs. Strong You are very worried about Ernie s health and Ima s outbursts of rage You identify verbal aggression as a key target symptom for treatment. You realize Ativan is a problem, but you also know that atypical antipsychotics such as risperidone can double mortality in demented patients You refer Ima for specialist assessment
32 Symptom Progression in AD 30 MMSE Mild AD Forgetfulness Short-term memory loss Repetitive questions Hobbies, interests lost Impaired instrumental functions Moderate AD Progression of cognitive deficits Aphasia Dysexecutive syndrome Severe AD Agitation Altered sleep patterns Anomia Impaired ADL Total dependence: Transitions in care dressing, feeding, bathing Years Adapted from Feldman & Woodward. Neurology. 2005;65:S10-7.
33 Management of Patients with Dementia 1. Define specific target symptoms A. ADL/IADL: e.g. household chores B. BEHAVIOUR: agitation/aggression/apathy C. COGNITION: memory, language, executive function 2. Consider rational pharmacologic treatment 3. Ensure non-pharmacologic management 4. Caregiver support, family education
34 Less Than Expected Decline: An Appropriate Treatment Goal in AD Hypothetical Treatment Expectations vs. Expected Decline in AD 1 functional abilities, behaviour, caregiver burden, quality of life, and resource utilisation all need to be comprehensively assessed to fully evaluate effects in patients with AD postponing or slowing decline in any of these areas may represent an important clinical benefit Geldmacher DS, et al. J Nutr Health Aging 2006;10:417-29; 2. Winblad B, et al. Int J Geriatr Psychiatry 2001;16:
35 Dementia IS NOT a test score
36 Key Points Dementia: IS loss of function due to cognitive loss IS NOT a test score Screen those at risk: 2 x 2 rule Identify target symptoms: A, B, C Consider non-pharmacologic and pharmacologic treatments First Link
37 Medical Management of Patients with Dementia: avoid Pitfalls 1. Recommended Guidelines for Treatment of a chronic disease may no longer apply. Diabetes Hypertension Specialized diets 2. Simplify medications as much as possible Avoid multiple doses, anticholinergics, benzodiazepines 3. Consider frailty and its impact on medical/surgical management and prognosis 4. What is important to the patient?
38 CSHA Frailty Scale Very fit Robust/active/energetic/well motivated/fitexercise regularly - most fit group for age Well Without active disease - less fit than group 1 Well, with treated co-morbid disease Disease symptoms well controlled compared with those in category 4 Apparently vulnerable Not frankly dependent, commonly complain being slowed up or have disease symptoms Mildly Frail With limited dependence on others for instrumental activities of daily living Moderately Frail Help is need with both instrumental and noninstrumental activities of daily living Severely frail Completely dependent on others for activities of daily living, or terminally ill
Diagnosis and Initial Management of Cognitive Disorders
Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical
More informationMontreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.
Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive
More informationPrediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment
Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Teresa Leung Therapist Prince of Wales Hospital 7 th May, 2012 Outline of Presentation Introduction Study Objectives,
More informationAlzheimer's: The Latest Assessment and Treatment Strategies
Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)
More informationPARTNERING WITH YOUR DOCTOR:
PARTNERING WITH YOUR DOCTOR: A Guide for Persons with Memory Problems and Their Care Partners Alzheimer s Association Table of Contents PARTNERING WITH YOUR DOCTOR: When is Memory Loss a Problem? 2 What
More informationPrimary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
More informationStaging and Treatment of Dementia
Staging and Treatment of Dementia Ami Hall DO 10/25/14 1 Objectives What are the two most common types of dementias seen in a primary care office How are they staged What treatments are available Definition
More informationAlzheimer s disease. What is Alzheimer s disease?
Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible
More informationUpdate on Treatment of the Dementias
Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label
More informationHow To Write Long Term Care Insurance
By Lori Boyce, AVP Risk Management and R&D Underwriting long term care insurance: a primer Every day Canadians die, are diagnosed with cancer, have heart attacks and become disabled and our insurance solutions
More informationObjectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit
Evaluation of Memory Loss and Mild Cognitive Impairment Skotti Church, MD Geriatrics Grand Rounds 4/3/2014 Objectives 1. Describe recommendations and tools for evaluation of cognitive impairment 2. Define
More informationCaregiving Issues for those with dementia and other cognitive challenges.
Caregiving Issues for those with dementia and other cognitive challenges. Sue Maxwell, MSW Director of Gerontology Lee Memorial Health System Fort Myers, Florida August 2009 Goals & Objectives Understand
More informationMemantine (Ebixa) Drug treatment for Alzheimer s disease
IS 20 October 2011 Information sheet Memantine (Ebixa) Drug treatment for Alzheimer s disease Introduction... 1 How does Ebixa work?... 1 Who might benefit?... 2 What effect might Ebixa have?... 2 How
More informationObjectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment
Dementia David Lam, MD, FRCPC, Psychiatry Assistant Clinical Professor Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario Objectives Aging and Forgetfulness Define
More informationAlzheimer s and Depression: What is the Connection?
Alzheimer s and Depression: What is the Connection? Ladson Hinton MD Professor and Director of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Director, Education Core, Alzheimer
More informationGeriatric Assessment Tools. Dr. Hermes
Geriatric Assessment Tools Dr. Hermes Geriatric Assessment Learning Objectives 1. Identify factors contributing to the need for specialized assessment of the frail older adult 2. Discuss the benefits of
More informationOccupational Therapy in Cognitive Rehabilitation
Occupational Therapy in Cognitive Rehabilitation Connie MS Lee Occupational therapist Queen Mary Hospital Hong Kong Cognition Cognition refers to mental processes that include the abilities to concentrate,
More informationGUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS
GUIDELINES GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS Preamble The American Society of Consultant Pharmacists has developed these guidelines for use of psychotherapeutic medications
More informationDEMENTIA AND MILD COGNITIVE IMPAIRMENT John P. Moriarty, MD Week 7
DEMENTIA AND MILD COGNITIVE IMPAIRMENT John P. Moriarty, MD Week 7 Educational Objectives: 1. Define dementia and mild cognitive impairment 2. Understand the appropriate work-up for patients with complaints
More informationCognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District
Cognitive Assessment and Mini Mental Status Exam for Nurses Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Objectives An understanding of what makes up a cognitive
More informationAlzheimer s disease. The importance of early diagnosis
Alzheimer s disease The importance of early diagnosis Key Facts Alzheimer s disease and other dementias 1 Alzheimer's disease is the leading form of dementia and accounts for 50%-75% of all cases. 1 Vascular
More informationThese guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes.
This is a new guideline. These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes. It incorporates NICE clinical
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More informationAssisted Living Nurse Competencies
Assisted Living Nurse Competencies Competencies Necessary for Nurses to Provide High-Quality Care to Older Adults in Assisted Living Residences 1. Recognize one s own and others attitudes, values, and
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationDoctor Visits. How Much to Participate
Family Caregiver Guide Doctor Visits Caregiving involves not only major crises, but also routine experiences like going to the doctor. HIPAA is a federal law that protects patient privacy, while allowing
More informationProgression EARLY STAGE. What is Alzheimer s disease? The early stage - what to expect
Progression EARLY STAGE This document is one in a five-part series on the stages of Alzheimer s disease and is written for the person with the disease, their family and caregivers. The early stage of the
More informationAlzheimer s disease. Reducing caregiver stress
Alzheimer s disease Reducing caregiver stress Supporting a person with Alzheimer s disease requires time and energy. While it can be a rewarding experience, it can also be demanding and stressful. Knowing
More informationChanging the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars
Changing the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars The appendices for this report including a detailed description of the model developed by The Lewin Group;
More informationManaging Care for Adults With Long-term Medical Illnesses. A Review of the Research
Managing Care for Adults With Long-term Medical Illnesses A Review of the Research Is This Information Right for Me? If you meet all of the following, this information is for you: You or someone you care
More informationConjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
More informationThe Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia
The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia By Scott Knight, Director, SLR Diagnostics & Assessments, a division of Sibley & Associates Inc., and Konstantine
More informationEarly Signs of Dementia. Purpose of Session: Early Signs of Dementia. Occasional Early Changes in Memory or Thinking Function
Early Signs of Dementia Prepared by: Leilani Doty, PhD, Director, University of Florida Cognitive & Memory Disorder Clinics (MDC), Box 100236, McKnight Brain Institute, Gainesville, FL 32610-0236, Office
More informationPrescribing Framework for Donepezil in the Treatment and Management of Dementia
Hull & East Riding Prescribing Committee Prescribing Framework for Donepezil in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP
More informationClinical Audit: Prescribing antipsychotic medication for people with dementia
Clinical Audit: Prescribing antipsychotic medication for people with dementia Trust, team and patient information Q1. Patient's DIS number... Q2. Patient s residence: Home Residential Home Nursing Home
More informationDiabetes in the elderly. Chris MacKnight April 2, 2011
Diabetes in the elderly Chris MacKnight April 2, 2011 Disclosure I have no conflict of interest to report Show of Hands 87 yo woman with diabetes and multiple other comorbidities, on multiple medications.
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More informationTECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management
TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management WHY IS THIS IMPORTANT? Depression causes fluctuations in mood, low self esteem and loss of interest or pleasure in normally
More informationDonepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease
IS 11 October 2011 Information sheet Donepezil hydrochloride (Aricept) Drug treatment for Alzheimer s disease Introduction... 1 How does Aricept work?... 1 Who might benefit from Aricept?... 2 What effect
More informationMeeting the Needs of Aging Persons. Aging in Individuals with a
Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed
More informationTraumatic brain injury (TBI)
Traumatic brain injury (TBI) A topic in the Alzheimer s Association series on understanding dementia. About dementia Dementia is a condition in which a person has significant difficulty with daily functioning
More informationDr. Patrick Healey is a board certified full time geriatrician. Undergraduate degree from Wabash College, a Masters degree in Teaching and a Medical
Dr. Patrick Healey is a board certified full time geriatrician. Undergraduate degree from Wabash College, a Masters degree in Teaching and a Medical degree from Indiana University. He completed an Internal
More informationTargeted Screening for Dementia
Targeted Screening for Dementia Dementia may be the most important health problem for the baby-boomer generation and healthcare system. As new disease-modifying drugs become available in the next decade,
More informationANXIETY & COGNITIVE IMPAIRMENT
ANXIETY & COGNITIVE IMPAIRMENT Dr. Sherri Hayden, Ph.D., R. Psych. Neuropsychologist, UBC Hospital Clinic for Alzheimer Disease & Related Disorders Clinical Assistant Professor, UBC Department of Medicine,
More informationSurvey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation
Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation On the following pages are a number of questions asking about the conditions under which you would prescribe anticoagulation
More informationCognitive Testing for Underwriting Life Insurance
Cognitive Testing for Underwriting Life Insurance Presentation to the Mortality Working Group of the International Actuarial Association Al Klein April 8, 2011 Cognitive function Agenda What is it? What
More informationDementia Friendly Health Care Setting
Dementia Friendly Health Care Setting Health care professionals play a key supportive role for people with dementia and their care partners. They can promote early diagnosis and provide ongoing medical
More informationNURSING B29 Gerontology Community Nursing. UNIT 2 Care of the Cognitively Impaired Elder in the Community
NURSING B29 Gerontology Community Nursing UNIT 2 Care of the Cognitively Impaired Elder in the Community INTRODUCTION The goal of this unit is for the learner to be able to differentiate between delirium,
More informationMontreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.
Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Suresh Kumar, M.D. AUTHOR Director of: Neurology & Headaches Center Inc. Neurocognitve &TBI Rehabilitation Center
More informationCRITERIA FOR AD DEMENTIA June 11, 2010
CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester
More informationLewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
More informationFrequently Asked Questions
Frequently Asked Questions Business Office: 598 Airport Boulevard Suite 1400 Morrisville NC 27560 Contact: support@cognitrax.com Phone: 888.750.6941 Fax: 888.650.6795 www.cognitrax.com Diseases of the
More informationAge Associated Cognitive Decline and Mild Cognitive Impairment (MCI)
Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry
More informationMY MEMORY BOOK. My Story IMPACT PROGRAM
MY MEMORY BOOK My Story IMPACT PROGRAM MY MEMORY BOOK My Story TABLE OF CONTENTS What is memory loss?... 1 About me... 6 My family history... 7 My story Education... 9 Awards and Recognition... 10 Work
More informationBedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College
Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial
More informationRecommended Geropsychiatric Competency Enhancements for Nurse Practitioners Who Provide Care to Older Adults but are not Geriatric Specialists
Recommended Geropsychiatric Competency Enhancements for Nurse Practitioners Who Provide Care to Older Adults but are not Geriatric Specialists These recommended competency enhancement statements are not
More informationHow to identify, approach and assist employees with young onset dementia: A guide for employers
How to identify, approach and assist employees with young onset dementia: A guide for employers What is dementia? Dementia involves the decline of cognitive functions. Young Onset Dementia, also known
More informationHEALTH 4 DEPRESSION, OTHER EMOTIONS, AND HEALTH
HEALTH 4 DEPRESSION, OTHER EMOTIONS, AND HEALTH GOALS FOR LEADERS To talk about the connection between certain emotions (anger, anxiety, fear, and sadness and health) To talk about ways to manage feelings
More information10 steps to planning for Alzheimer s disease & other dementias A guide for family caregivers
10 steps to planning for Alzheimer s disease & other dementias A guide for family caregivers Caring for a person with memory loss or dementia can be challenging. The following ten steps can help caregivers
More informationWhat is vascular dementia?
alzheimers.org.uk What is vascular dementia? Vascular dementia is the second most common form of dementia after Alzheimer s disease. It is caused by problems in the supply of blood to the brain. This factsheet
More informationPharmacists improving care in care homes
The Royal Pharmaceutical Society believes that better utilisation of pharmacists skills in care homes will bring significant benefits to care home residents, care homes providers and the NHS. Introduction
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationDisclosures. Case: Ms. K. Case: Ms. K. Dementia: Considering When to Start, Stop, and Continue Medications 4/23/15. * Nothing to disclose
Dementia: Considering When to Start, Stop, and Continue Medications * Nothing to disclose Disclosures Lianne Hirano, MD UW Division of Gerontology & Geriatric Medicine 4/23/15 Current Concepts in Drug
More informationBasics of Dementia Third Session: Progressive Memory Disorders (3rd edition, 3/27/07)
Basics of Dementia Third Session: Progressive Memory Disorders (3rd edition, 3/27/07) Prepared by: Leilani Doty, PhD, Administrator University of Florida Memory Disorder Clinic McKnight Brain Institute,
More informationCollaborative Care for Alzheimer s Disease
The Health Care Workforce for Older Americans: Promoting Team Care Institute of Medicine Symposium October 2008 Collaborative Care for Alzheimer s Disease Christopher M. Callahan, MD Cornelius and Yvonne
More informationDeprivation of liberty in health and social care
Briefing For: Health and Social Care Providers Date: 16/04/2014 Issue Deprivation of liberty in health and social care On 19 March 2014, the Supreme Court handed down its judgment in the case of P v Cheshire
More informationThe Doctor-Patient Relationship
The Doctor-Patient Relationship It s important to feel at ease with your doctor. How well you are able to talk with your doctor is a key part of getting the care that s best for you. It s also important
More informationADDENBROOKE'S COGNITIVE EXAMINATION - ACE-R Final Revised Version A (2005)
Final Revised Version A (2005) Name : Date of birth : Hospital no. : O R I E N T A T I O N Ask: What is the Ask: Which R E G I S T R A T I O N Register number of trials Day Building Addressograph Date
More informationSteps to getting a diagnosis: Finding out if it s Alzheimer s Disease.
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have
More informationMalattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista
55 Congresso Nazionale SIG Firenze Auditorium Palazzo dei Congressi 2 Dicembre 2010 Invecchiamento e Longevità: più Geni o più Ambiente Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento
More informationWritten Example for Research Question: How is caffeine consumption associated with memory?
Guide to Writing Your Primary Research Paper Your Research Report should be divided into sections with these headings: Abstract, Introduction, Methods, Results, Discussion, and References. Introduction:
More informationAntipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers
SUPPLEMENT 1: (Supplementary Material for online publication) Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers About this
More informationFinancial Advisors and Alzheimer s Disease: What You Need to Know
Financial Advisors and Alzheimer s Disease: What You Need to Know In today s aging society, with people living longer lives, chances are good that you ll be called upon to assist clients who have Alzheimer
More informationSlide 1. Prior to the memory team there were a number of different pathways for the diagnosis and treatment of those suffering from dementia
1 Talk for High Performance Conference: The Counties Manukau Memory Team Slide 1 Where did the Memory Team come from? Sue Thompson, Northern Regional Dementia Advisor for the Ministry of Health and Dr
More informationAntipsychotics in people with dementia an update and reminder
www.bpac.org.nz keyword: dementia Antipsychotics in people with dementia an update and reminder Key concepts: Non-pharmacological treatments for the behavioural and psychological symptoms of dementia (BPSD)
More informationJohns Hopkins Memory & Alzheimer s Treatment Center
Memory is The Memory Center has not only provided great care to my husband, but also has helped me learn to care for myself while caring for him. - Sylvia Mackey Have you forgotten someone s name you should
More informationADDENBROOKE S COGNITIVE EXAMINATION ACE-R
ACE-R Guide 26 ADDENBROOKE S COGNITIVE EXAMINATION ACE-R Administration and Scoring Guide - 26 The ACE-R 1 is a brief cognitive test that assesses five cognitive domains, namely attention/orientation,
More informationOverview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013
Overview Neuropsychological Assessment in Stroke Brandon Ally, PhD Department of Neurology What is Neuropsychology Stroke Specific Neuropsychology Neuropsychological Domains Case Study What is Neuropsychology?
More informationEvaluations. Viewer Call-In. www.t2b2.org. Phone: 800-452-0662 Fax: 518-426-0696. Geriatric Mental Health. Thanks to our Sponsors: Guest Speaker
Geriatric Mental Health June 1, 7 Guest Speaker Michael B. Friedman, LMSW Chairperson Geriatric Mental Health Alliance of New York Thanks to our Sponsors: School of Public Health, University at Albany
More informationRehabilitation Integrated Transition Tracking System (RITTS)
Rehab Criteria The patient must have a physical impairment requiring rehabilitation OR have a known cognitive impairment requiring ongoing rehabilitation support or services. The patient is medically stable:
More informationCopywrite - Eric Freitag, Psy.D., 2012
Diagnosis, Intervention and Care for Patients With Cognitive Impairment Eric J. Freitag, Psy.D, FACPN Diplomate, American College of Professional Neuropsychology Mt. Diablo Memory Center Founder/Executive
More informationNEUROPSYCHOLOGY QUESTIONNAIRE. (Please fill this out prior to your appointment and bring it with you.) Name: Date of appointment: Home address:
NEUROPSYCHOLOGY QUESTIONNAIRE (Please fill this out prior to your appointment and bring it with you.) Name: Date of appointment: Date of birth: Age: _ Home address: _ Home phone: Cell phone: Work phone:
More information2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease
2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,
More informationPatients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by
Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years
More informationTahitian Pearls 2015 Tahiti CME Cruise March 18 28, 2015. Legal aspects of geriatric psychiatry: MD s Obligations Dr.
Legal Issues in the Elderly Kiran Rabheru MD, CCFP, FRCP Geriatric Psychiatrist Professor University of Ottawa www.seacourses.com 1 www.seacourses.com 2 www.seacourses.com 3 www.seacourses.com 4 2.8 4.6%
More informationThe Independent In-Person Assessment Process
The Independent In-Person Assessment Process Jocelyn Gordon, Marc A. Cohen, and Jessica Miller Spring 2011 No. 4 The Community Living Assistance Services and Supports (CLASS) Plan a groundbreaking component
More informationLong Term Care Formulary HCD - 09. Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)
1 of 8 USE OF CHOLINESTERASE (AChE) INHIBITORS The cholinesterase inhibitor anti-dementia drugs are indicated for the symptomatic treatment of patients with mild to moderate dementia of the Alzheimer s
More informationTreating Depression to Remission in the Primary Care Setting. James M. Slayton, M.D., M.B.A. Medical Director United Behavioral Health
Treating Depression to Remission in the Primary Care Setting James M. Slayton, M.D., M.B.A. Medical Director United Behavioral Health 2007 United Behavioral Health 1 2007 United Behavioral Health Goals
More informationDonepezil, galantamine, rivastigmine and memantine for Alzheimer s disease
Understanding NICE guidance Information for people who use NHS services Donepezil, galantamine, rivastigmine and memantine for Alzheimer s disease NICE technology appraisal guidance advises on when and
More informationNeuropsychiatry Disorders
Neuropsychiatry Disorders Larry Fisher, Ph.D., ABN UHS Neurobehavioral Systems (Copyright UHS 2009; All rights reserved) For more information: Larry Fisher, Ph.D., ABN UHS Neurobehavioral Systems 12710
More informationProgression MIDDLE STAGE. What is Alzheimer s disease?
Progression MIDDLE STAGE This document is one in a five-part series on the stages of Alzheimer s disease and is written for the person with the disease, their family and caregivers. The middle stage of
More informationSutter Health, based in Sacramento, California and
FACES of HOME HEALTH Caring for Frail Elderly Patients in the Home Sutter Health, based in Sacramento, California and serving Northern California, partners with its home care affiliate Sutter Care at Home,
More informationDepression. What Causes Depression?
National Institute on Aging AgePage Depression Everyone feels blue now and then. It s part of life. But, if you no longer enjoy activities that you usually like, you may have a more serious problem. Feeling
More informationRobert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
More informationIntegrated Neuropsychological Assessment
Integrated Neuropsychological Assessment Dr. Diana Velikonja C.Psych Neuropsychology, Hamilton Health Sciences, ABI Program Assistant Professor, Psychiatry and Behavioural Neurosciences Faculty of Health
More informationPrimary Endpoints in Alzheimer s Dementia
Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in
More informationNo Dementia Stage 2: Very Mild Cognitive Decline
Stages of Dementia Health professionals sometimes discuss dementia in "stages," which refers to how far a person's dementia has progressed. Defining a person's disease stage helps physicians determine
More informationCoenzyme Q10. Information Sheet
Coenzyme Q10 What is Coenzyme Q10? Coenzyme Q10 (or CoQ10) is a substance present in every cell of the body. A coenzyme is a very small molecule that enhances the function of enzymes, particularly in the
More informationLong-Term Care: Frequently Asked Questions About Long- Term Care Insurance
FACT SHEET LTC: FAQ s About Long-Term Care Insurance (H-003) p. 1 of 5 Long-Term Care: Frequently Asked Questions About Long- Term Care Insurance Long-Term Care (LTC) insurance only pays for long-term
More informationPART I : NAVIGATING HEALTH CARE
PART I : NAVIGATING HEALTH CARE SECTION ONE Hospitals, Clinical Trials & Ambulance Service 1. Should my dad just sign all those hospital consent forms or actually question them? 2. What is a hospital Patient
More information